Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response.

Zafarnia S, Bzyl-Ibach J, Spivak I, Li Y, Koletnik S, Doleschel D, Rix A, Pochon S, Tardy I, Koyadan S, van Zandvoort M, Palmowski M, Kiessling F, Lederle W.

Neoplasia. 2017 Nov;19(11):896-907. doi: 10.1016/j.neo.2017.08.009. Epub 2017 Sep 20.

2.

Erratum to: In situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.

Ehling J, Misiewicz M, von Stillfried S, Möckel D, Bzyl J, Pochon S, Lederle W, Knuechel R, Lammers T, Palmowski M, Kiessling F.

Angiogenesis. 2016 Jul;19(3):449. No abstract available.

PMID:
27025391
3.

In situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.

Ehling J, Misiewicz M, von Stillfried S, Möckel D, Bzyl J, Pochon S, Lederle W, Knuechel R, Lammers T, Palmowski M, Kiessling F.

Angiogenesis. 2016 Apr;19(2):245-254. doi: 10.1007/s10456-016-9499-4. Epub 2016 Feb 22. Erratum in: Angiogenesis. 2016 Jul;19(3):449.

4.

[Molecular ultrasound imaging: Clinical applications].

Rix A, Palmowski M, Kiessling F.

Radiologe. 2015 Nov;55(11):956-63. doi: 10.1007/s00117-015-0023-4. Review. German.

PMID:
26438094
5.

Diagnosis of pulmonary embolism: conventional ventilation/perfusion SPECT is superior to the combination of perfusion SPECT and nonenhanced CT.

Palmowski K, Oltmanns U, Kreuter M, Mottaghy FM, Palmowski M, Behrendt FF.

Respiration. 2014;88(4):291-7. doi: 10.1159/000365817. Epub 2014 Aug 30.

6.

Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.

Rix A, Palmowski M, Gremse F, Palmowski K, Lederle W, Kiessling F, Bzyl J.

Ultrasound Med Biol. 2014 Oct;40(10):2468-75. doi: 10.1016/j.ultrasmedbio.2014.04.010. Epub 2014 Jul 9.

PMID:
25023096
7.

Prognostic relevance of (18)F-FDG PET/CT in carcinoma of unknown primary.

Breuer N, Behrendt FF, Heinzel A, Mottaghy FM, Palmowski M, Verburg FA.

Clin Nucl Med. 2014 Feb;39(2):131-5. doi: 10.1097/RLU.0000000000000304.

PMID:
24368527
8.

Recent advances in molecular, multimodal and theranostic ultrasound imaging.

Kiessling F, Fokong S, Bzyl J, Lederle W, Palmowski M, Lammers T.

Adv Drug Deliv Rev. 2014 Jun;72:15-27. doi: 10.1016/j.addr.2013.11.013. Epub 2013 Dec 4. Review.

9.

A low molecular weight zinc2+-dipicolylamine-based probe detects apoptosis during tumour treatment better than an annexin V-based probe.

Palmowski K, Rix A, Lederle W, Behrendt FF, Mottaghy FM, Gray BD, Pak KY, Palmowski M, Kiessling F.

Eur Radiol. 2014 Feb;24(2):363-70.

PMID:
24121671
10.

The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.

Verburg FA, Kuhl CK, Pietsch H, Palmowski M, Mottaghy FM, Behrendt FF.

Eur J Radiol. 2013 Oct;82(10):e617-22. doi: 10.1016/j.ejrad.2013.06.020. Epub 2013 Jul 20.

PMID:
23880426
11.

Ultrasound molecular imaging of E-selectin in tumor vessels using poly n-butyl cyanoacrylate microbubbles covalently coupled to a short targeting peptide.

Fokong S, Fragoso A, Rix A, Curaj A, Wu Z, Lederle W, Iranzo O, Gätjens J, Kiessling F, Palmowski M.

Invest Radiol. 2013 Dec;48(12):843-50. doi: 10.1097/RLI.0b013e31829d03ec.

PMID:
23857137
12.

Simultaneous dual-isotope SPECT/CT with (99m)Tc- and (111)In-labelled albumin microspheres in treatment planning for SIRT.

Palmowski M, Goedicke A, Vogg A, Christ G, Mühlenbruch G, Kaiser HJ, Günther RW, Kuhl CK, Mottaghy FM, Behrendt FF.

Eur Radiol. 2013 Nov;23(11):3062-70. doi: 10.1007/s00330-013-2916-9. Epub 2013 Jun 16.

PMID:
23771601
13.

Molecular and functional ultrasound imaging of breast tumors.

Bzyl J, Lederle W, Palmowski M, Kiessling F.

Eur J Radiol. 2012 Sep;81 Suppl 1:S11-2. doi: 10.1016/S0720-048X(12)70005-0. No abstract available.

PMID:
23083550
14.

Identification of the iodine concentration that yields the highest intravascular enhancement in MDCT angiography.

Behrendt FF, Pietsch H, Jost G, Palmowski M, Günther RW, Mahnken AH.

AJR Am J Roentgenol. 2013 May;200(5):1151-6. doi: 10.2214/AJR.12.8984.

PMID:
23617503
15.

Accuracy of a clinical PET/CT vs. a preclinical μPET system for monitoring treatment effects in tumour xenografts.

Palmowski K, Winz O, Rix A, Bzyl J, Behrendt FF, Verburg FA, Mottaghy FM, Palmowski M.

Eur J Radiol. 2013 Aug;82(8):1318-24. doi: 10.1016/j.ejrad.2013.01.028. Epub 2013 Feb 26.

PMID:
23452987
16.

Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment.

Grouls C, Hatting M, Rix A, Pochon S, Lederle W, Tardy I, Kuhl CK, Trautwein C, Kiessling F, Palmowski M.

Radiology. 2013 May;267(2):487-95. doi: 10.1148/radiol.13120220. Epub 2013 Jan 29.

PMID:
23360735
17.

Evaluation of bone substitute materials: comparison of flat-panel based volume CT to conventional multidetector CT.

Sauerbier S, Duttenhoefer F, Sachlos E, Haberstroh J, Scheifele C, Wrbas KT, Voss PJ, Veigel E, Smedek J, Ganter P, Tuna T, Gutwald R, Palmowski M.

J Craniomaxillofac Surg. 2013 Oct;41(7):e128-36. doi: 10.1016/j.jcms.2012.11.039. Epub 2013 Jan 16.

PMID:
23332471
18.

The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55).

Bzyl J, Palmowski M, Rix A, Arns S, Hyvelin JM, Pochon S, Ehling J, Schrading S, Kiessling F, Lederle W.

Eur Radiol. 2013 Feb;23(2):468-75. doi: 10.1007/s00330-012-2594-z. Epub 2012 Aug 10.

PMID:
22878592
19.

Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.

Prechtel HW, Verburg FA, Palmowski M, Krohn T, Pietsch H, Kuhl CK, Mottaghy FM, Behrendt FF.

Invest Radiol. 2012 Sep;47(9):497-502. doi: 10.1097/RLI.0b013e31825d676e.

PMID:
22820678
20.

Endovascular broad-neck aneurysm creation in a porcine model using a vascular plug.

Mühlenbruch G, Nikoubashman O, Steffen B, Dadak M, Palmowski M, Wiesmann M.

Cardiovasc Intervent Radiol. 2013 Feb;36(1):239-44. doi: 10.1007/s00270-012-0431-z. Epub 2012 Jun 27.

PMID:
22735890
21.

PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessment.

Behrendt FF, Temur Y, Verburg FA, Palmowski M, Krohn T, Pietsch H, Kuhl CK, Mottaghy FM.

Eur Radiol. 2012 Nov;22(11):2458-64. doi: 10.1007/s00330-012-2515-1. Epub 2012 Jun 4.

PMID:
22661058
22.

Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.

Rebière M, Verburg FA, Palmowski M, Krohn T, Pietsch H, Kuhl CK, Mottaghy FM, Behrendt FF.

Eur J Radiol. 2012 Aug;81(8):e862-9. doi: 10.1016/j.ejrad.2012.04.007. Epub 2012 May 15.

PMID:
22591760
23.

MRI-based attenuation correction for hybrid PET/MRI systems: a 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence.

Berker Y, Franke J, Salomon A, Palmowski M, Donker HC, Temur Y, Mottaghy FM, Kuhl C, Izquierdo-Garcia D, Fayad ZA, Kiessling F, Schulz V.

J Nucl Med. 2012 May;53(5):796-804. doi: 10.2967/jnumed.111.092577. Epub 2012 Apr 13. Erratum in: J Nucl Med. 2012 Sep;53(9):1496.

24.

Development and validation of an intrinsic landmark-based gating protocol applicable for functional and molecular ultrasound imaging.

Grouls C, Hatting M, Tardy I, Bzyl J, Mühlenbruch G, Behrendt FF, Penzkofer T, Trautwein C, Kuhl C, Kiessling F, Palmowski M.

Eur Radiol. 2012 Aug;22(8):1789-96. doi: 10.1007/s00330-012-2429-y. Epub 2012 Mar 30.

PMID:
22460059
25.

Targeted ultrasound imaging of cancer: an emerging technology on its way to clinics.

Kiessling F, Bzyl J, Fokong S, Siepmann M, Schmitz G, Palmowski M.

Curr Pharm Des. 2012;18(15):2184-99. Review.

PMID:
22352772
26.

Imaging in the age of molecular medicine: monitoring of anti-angiogenic treatments.

Lederle W, Palmowski M, Kiessling F.

Curr Pharm Biotechnol. 2012 Mar;13(4):595-608. Review.

PMID:
22214504
27.

Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects.

Lederle W, Arns S, Rix A, Gremse F, Doleschel D, Schmaljohann J, Mottaghy FM, Kiessling F, Palmowski M.

EJNMMI Res. 2011 Nov 17;1(1):26. doi: 10.1186/2191-219X-1-26.

28.

18F-FDG-PET/CT in myelofibrosis.

Behrendt FF, Krohn T, Palmowski M, Mottaghy FM.

Nuklearmedizin. 2011;50(6):N66-7. No abstract available.

PMID:
22138707
29.

Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment.

Rix A, Lederle W, Siepmann M, Fokong S, Behrendt FF, Bzyl J, Grouls C, Kiessling F, Palmowski M.

Eur J Radiol. 2012 Oct;81(10):2710-6. doi: 10.1016/j.ejrad.2011.10.004. Epub 2011 Nov 17.

PMID:
22093958
30.

Virtual elastic sphere processing enables reproducible quantification of vessel stenosis at CT and MR angiography.

Gremse F, Grouls C, Palmowski M, Lammers T, de Vries A, Grüll H, Das M, Mühlenbruch G, Akhtar S, Schober A, Kiessling F.

Radiology. 2011 Sep;260(3):709-17. doi: 10.1148/radiol.11110069. Epub 2011 Jul 25.

PMID:
21788527
31.

Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).

Bzyl J, Lederle W, Rix A, Grouls C, Tardy I, Pochon S, Siepmann M, Penzkofer T, Schneider M, Kiessling F, Palmowski M.

Eur Radiol. 2011 Sep;21(9):1988-95. doi: 10.1007/s00330-011-2138-y. Epub 2011 May 12.

PMID:
21562807
32.

Application of molecular ultrasound for imaging integrin expression.

Kiessling F, Gaetjens J, Palmowski M.

Theranostics. 2011 Feb 1;1:127-34.

33.

Current role and future perspective of MRI for diagnosis and characterization of renal cell carcinoma.

Schoth F, Persigehl T, Palmowski M.

Panminerva Med. 2010 Dec;52(4):307-18. Review.

PMID:
21183891
34.

[Bilateral adrenal vein sampling in single catheter technique using a 4F cobra catheter in regular and inverse configuration].

Palmowski M, Mühlenbruch G, Grouls C, Günther RW.

Rofo. 2011 Feb;183(2):167-70. doi: 10.1055/s-0029-1245588. Epub 2010 Aug 19. German.

PMID:
20725877
35.

MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression.

Woenne EC, Lederle W, Zwick S, Palmowski M, Krell H, Semmler W, Mueller MM, Kiessling F.

Anticancer Res. 2010 Mar;30(3):703-11.

PMID:
20392987
36.

Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound.

Palmowski M, Lederle W, Gaetjens J, Socher M, Hauff P, Bzyl J, Semmler W, Günther RW, Kiessling F.

Eur J Radiol. 2010 Jul;75(1):e149-53. doi: 10.1016/j.ejrad.2009.10.030. Epub 2009 Nov 27.

PMID:
19945241
37.

Intrarenal artery delineation with ultra high resolution, flat panel based, volume computerized tomography: outer limits of spatial resolution.

Neukamm M, Palmowski M, Bartling S, Schawo S, Rietdorf U, Meinzer HP, Hohenfellner M, Kauczor HU, Hallscheidt P.

J Urol. 2009 Dec;182(6):2915-9. doi: 10.1016/j.juro.2009.08.017. Epub 2009 Oct 28.

PMID:
19846147
38.

Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions.

Palmowski M, Peschke P, Huppert J, Hauff P, Reinhardt M, Maurer M, Karger CP, Scholz M, Semmler W, Huber PE, Kiessling FM.

Neoplasia. 2009 Sep;11(9):856-63.

39.

Tumor perfusion assessed by dynamic contrast-enhanced MRI correlates to the grading of renal cell carcinoma: initial results.

Palmowski M, Schifferdecker I, Zwick S, Macher-Goeppinger S, Laue H, Haferkamp A, Kauczor HU, Kiessling F, Hallscheidt P.

Eur J Radiol. 2010 Jun;74(3):e176-80. doi: 10.1016/j.ejrad.2009.05.042. Epub 2009 Jun 21.

PMID:
19540690
40.

[Molecular imaging in oncology using targeted ultrasound contrast agents].

Palmowski M, Palmowski M, Hauff P, Kiessling F.

Praxis (Bern 1994). 2009 May 27;98(11):597-602. doi: 10.1024/1661-8157.98.11.597. Review. German.

PMID:
19472145
41.

[High-resolution imaging of the layers of the gastrointestinal wall of pig and human specimens using an endoluminal MR receiver coil: correlation to histology].

Kramer S, Palmowski M, Macher-Göppinger S, Müller M, Volke F, Düx M, Kauczor HU, Grenacher L.

Rofo. 2009 Nov;181(11):1073-80. doi: 10.1055/s-0028-1109389. Epub 2009 Apr 30. German.

PMID:
19408212
42.

Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging.

Zwick S, Strecker R, Kiselev V, Gall P, Huppert J, Palmowski M, Lederle W, Woenne EC, Hengerer A, Taupitz M, Semmler W, Kiessling F.

J Magn Reson Imaging. 2009 May;29(5):1125-33. doi: 10.1002/jmri.21710.

PMID:
19388117
43.

Onset and maintenance of angiogenesis in biomaterials: in vivo assessment by dynamic contrast-enhanced MRI.

Sauerbier S, Palmowski M, Vogeler M, Nagursky H, Al-Ahmad A, Fisch D, Hennig J, Schmelzeisen R, Gutwald R, Fasol U.

Tissue Eng Part C Methods. 2009 Sep;15(3):455-62. doi: 10.1089/ten.tec.2008.0626.

PMID:
19348591
44.

A single-chain H-2Db molecule presenting an influenza virus nucleoprotein epitope shows enhanced ability at stimulating CD8+ T cell responses in vivo.

Palmowski MJ, Parker M, Choudhuri K, Chiu C, Callan MF, van der Merwe PA, Cerundolo V, Gould KG.

J Immunol. 2009 Apr 15;182(8):4565-71. doi: 10.4049/jimmunol.0803893.

45.

Functional and molecular ultrasound imaging: concepts and contrast agents.

Kiessling F, Huppert J, Palmowski M.

Curr Med Chem. 2009;16(5):627-42. Review.

PMID:
19199927
46.

Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment.

Palmowski M, Huppert J, Hauff P, Reinhardt M, Schreiner K, Socher MA, Hallscheidt P, Kauffmann GW, Semmler W, Kiessling F.

Cancer Res. 2008 Sep 1;68(17):7042-9. doi: 10.1158/0008-5472.CAN-08-0285.

47.

Metastasis to the pancreas: characterization by morphology and contrast enhancement features on CT and MRI.

Palmowski M, Hacke N, Satzl S, Klauss M, Wente MN, Neukamm M, Kleeff J, Hallscheidt P.

Pancreatology. 2008;8(2):199-203. doi: 10.1159/000128556. Epub 2008 Apr 23.

PMID:
18434757
48.

CT and endoscopic ultrasound in comparison to endoluminal MRI: preliminary results in staging gastric carcinoma.

Heye T, Kuntz C, Düx M, Encke J, Palmowski M, Autschbach F, Volke F, Kauffmann GW, Grenacher L.

Eur J Radiol. 2009 May;70(2):336-41. doi: 10.1016/j.ejrad.2008.01.037. Epub 2008 Mar 11.

PMID:
18337043
49.

Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging.

Palmowski M, Morgenstern B, Hauff P, Reinhardt M, Huppert J, Maurer M, Woenne EC, Doerk S, Ladewig G, Jenne JW, Delorme S, Grenacher L, Hallscheidt P, Kauffmann GW, Semmler W, Kiessling F.

Invest Radiol. 2008 Mar;43(3):162-9. doi: 10.1097/RLI.0b013e31815a251b.

PMID:
18301312
50.

[Differential diagnosis of renal tumors].

Hallscheidt P, Haferkamp A, Lopez-Benitez R, Palmowski M.

Radiologe. 2008 Mar;48(3):293-302; quiz 303. doi: 10.1007/s00117-008-1632-y. Review. German.

PMID:
18278476

Supplemental Content

Loading ...
Support Center